|When is the best time to exercise?
|Too much coffee might be bad - for some
|Lower risk of adverse pregnancy outcomes with a Mediterranean diet
|Stay sharp with flavonols
|Salting at the table
|On time - and Velveeta
|Cut calories vs. cut protein intake: the results will surprise you
|Mediterranean Diet Improves Symptoms of Depression in Young Men
|Weight and vision
|When you eat might matter more than previously thought
|All Health and Nutrition Bites
At our 2021 Health meets Food: the Culinary Medicine Conference, we're offering a session on health coaching as well as one on Diabetes Prevention. Find out more »
Underscoring the importance of moderate exercise
Current recommendations are for adults to engage in at least 150 minutes of "moderate-to-vigorous physical activity" each week for reasons including improved cardiovascular outcomes.
A little movement yields big benefits
The Dr. Gourmet mission is primarily about food and eating healthier, but I can't ignore the impact that exercise can have on your health.
Prevent Diabetes without Losing Weight
Hundreds upon hundreds of well-designed studies document the positive effects of a Mediterranean-style diet upon blood pressure, cholesterol scores, and conditions both major and (comparatively) minor as heart disease, cancer, Alzheimer's Disease, pneumonia, and osteoporosis. We also know that a Mediterranean diet can help prevent diabetes.
The step-by-step guide to a Mediterranean Diet
Dr. Tim Harlan's best tips and recipes in a six-week plan for you to learn how to follow a Mediterranean-style diet while still eating foods you know and love. Just $15.00 +s/h!
Get the latest health and diet news - along with what you can do about it - sent to your Inbox once a week. Get Dr. Gourmet's Health and Nutrition Bites sent to you via email. Sign up now!
In 1996 a team of researchers with funding from multiple US governmental research centers designed a study known as the Diabetes Prevention Program Research Group to compare the impact of an intensive lifestyle change regimen, medication, or placebo on the risk of developing diabetes.
The over 3,200 participants averaged 51 years of age and had an average Body Mass Index of 34 (clinically obese). All had elevated fasting glucose concentrations indicating that they were pre-diabetic (but not diabetic), and at least half of the participants were from "racial or ethnic minority groups."
The participants were randomly assigned to receive a twice-daily dose of metformin, a twice-daily dose of placebo, or were assigned to an intensive lifestyle counseling regimen that aimed to help the participants lose about 7% of their body weight and keep it off while also performing a minimum of 150 minutes of moderate-intensity exercise each week.
The study had originally aimed to last into 2002 but was terminated one year early due to its positive results. Those in the lifestyle arm of the study were 58% less likely to develop diabetes than those in the placebo group, while those taking metformin were 31% less likely to develop diabetes than those in the placebo group.
Today's research is an extension of that study (Diab Care 2021;44:43-49). At the end of the original research all participants were invited to participate in a version of the intensive lifestyle change regimen that had been so successful. Those who had been taking metformin continued taking the medication while placebo administration was discontinued.
The authors continued monitoring the nearly 1,800 participants who chose to continue to participate in the study, which lasted an average of 12 years for each participant.
Once again, the outcome measure was whether a participant developed diabetes as diagnosed by an oral glucose tolerance test.
On an annual basis the authors surveyed the participants as to their levels of physical activity. A representative percentage of the participants consented to wear accelerometers (motion sensors) for a 7-day period to measure not only their moderate or vigorous activity but also their light-intensity activity.
At the close of the study the authors assessed the risk of developing diabetes according to the participant's activity level, taking into account age, sex, weight at the start of the study, weight loss, and the usual amount of physical activity the participant engaged in at the start of the study.
For every additional 17 minutes of brisk daily walking, the participants saw a 6% reduction in their risk of developing diabetes. Those whose regular activity at the start of the study was under the recommended 150 minutes per week, but increased their activity to that level, actually reduced their risk of diabetes by 12%.
The lifestyle change program emphasized meeting the target of at least 150 minutes per week of moderate-intensity exercise (i.e., brisk walking), which is relatively equivalent to 300 minutes of light-intensity exercise (i.e., shopping, doing the dishes).
What's interesting is that of the three arms of the study - lifestyle, metformin, and placebo - those in the lifestyle arm didn't exercise all that much more than the other two arms. The lifestyle arm averaged 20.7 minutes of moderate-intensity exercise and 363.5 minutes of light-intensity exercise per day, while the metformin and placebo groups averaged 19.6 and 353.3 minutes of light-intensity exercise. That's not a huge difference.
Your take-home here should be that even if you are overweight, exercise is an important tool in preventing diabetes. As the authors of this study put it, "[We] urge health care professionals to look beyond their high-risk patient's weight and consider his or her habitual [physical activity] levels when discussing lifestyle strategies to prevent progression to type 2 diabetes."
First posted: April 14, 2021